WHANIN PHARM CO.,LTD
Develops and sells pharmaceuticals, specializing in CNS, cardiovascular, and GI drugs.
016580 | KO
Overview
Corporate Details
- ISIN(s):
- KR7016580003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 법원로6길 11 (문정동, 환인빌딩), 서울특별시
- Website:
- https://www.whanin.com/?lang=eng
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Whanin Pharm Co., Ltd. is a pharmaceutical company focused on the development, manufacturing, and sale of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), offering a range of neuropsychiatric drugs including anti-depressants, anti-psychotics, and nootropics. In addition to its core CNS portfolio, Whanin Pharm also produces pharmaceuticals for other therapeutic categories such as cardiovascular and gastrointestinal treatments, as well as antibiotics. The company actively engages in research and development to create innovative medications, extending its focus beyond CNS to the broader healthcare sphere.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-13 00:00 |
Annual Report
[기재정정]사업보고서 (2024.12)
|
Korean | 1.7 MB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.4 MB | ||
| 2025-08-01 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.9 KB | ||
| 2025-07-11 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 19.7 KB | ||
| 2025-07-07 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 30.6 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.3 MB | ||
| 2025-04-30 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 15.9 KB | ||
| 2025-03-21 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.8 KB | ||
| 2025-03-21 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 24.9 KB | ||
| 2025-03-13 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 20.1 KB | ||
| 2025-03-13 00:00 |
Annual Report
사업보고서 (2024.12)
|
Korean | 1.8 MB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 830.1 KB | ||
| 2025-03-05 00:00 |
Pre-Annual General Meeting Information
주주총회집중일개최사유신고
|
Korean | 4.9 KB | ||
| 2025-02-28 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 8.4 KB | ||
| 2025-02-28 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 13.7 KB |
Automate Your Workflow. Get a real-time feed of all WHANIN PHARM CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for WHANIN PHARM CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for WHANIN PHARM CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
